Willow

Willow (operating under startwillow.com, legally Willow Health Services, Inc.) is a digital telehealth and weight management platform that provides personalized, doctor-guided GLP-1 care. Founded in 2021 by John Errico, Willow connects patients with board-certified physicians and licensed pharmacies to deliver custom-formulated compounded weight loss medications, including sublingual Semaglutide tablets, weekly Semaglutide injections, and Tirzepatide. Through its 100% online telehealth platform, Willow offers medical assessments, ongoing physician support, customized metabolic treatment plans, and direct-to-door FSA/HSA-eligible prescription delivery. Headquartered in Austin, Texas, Willow operates across the United States to make scientific weight loss care affordable and accessible.